Upload
doxuyen
View
220
Download
3
Embed Size (px)
Citation preview
5th International Workshop On The Treatment Of Hepatic And Lung Metastases Of Colorectal Carcinoma
www.oncology-bcn.com
November 12th and 13th, 2015.Hotel NH Barcelona Constanza. Barcelona, Spain.
5th International Workshop On The Treatment Of Hepatic And Lung Metastases Of Colorectal Carcinoma
November 12th and 13th, 2015.Hotel NH Barcelona Constanza. Barcelona, Spain.
Organised by:
Fundació Docència i Recerca MútuaTerrassa
The most common metastasic localizations of colorectal cancer occur in the liver and
the lungs. Multidisciplinary treatment of patients suffering from metastasic localization
of colorectal cancer has shown encouraging results in improving the chances for a cure.
The Workshop is focusing on the state-of-the art of the multimodal management of
lung and liver metastases.
We invite you to activaly participate In the scientific programme.
We look forward to a memorable meeting and hope to see you in Barcelona!
Dr. Lluís CireraWhorkshop Chairman
www.oncology-bcn.com
Dr. Esteban Cugat Dr. Ramón Rami-PortaWorkshop’s Vice-Chairmen
CommiteesWorkshop coordinators:Chairman: Lluís Cirera
Vice-Chairmen: Esteban Cugat, Ramón Rami-Porta
Organizing committee:José Belda
Sergi Call
Esther Casado
Lluís Cirera
Esteban Cugat
Julen Fernández
Carmen Ferrer
Maribel García
Eric Herrero
José Angel de Marcos
Ramón Rami-Porta
Antonio Salas
Scientific committee:Rene Adam
Sergi Call
Lluís Cirera
Esteban Cugat
Joan Figueras
Jesús García-Foncillas
Clara Montagut
Ramón Rami-Porta
Programme
Programme Thursday, November 12th, 2015
10.00 Registration
10.45- 11.00 Welcome and Presentation Lluís Cirera
11.00- 14.00 SPONSORED SYMPOSIUMS
14.10- 15.10 Lunch
14.10- 20.00 POSTER DISPLAY
15.45- 17.00 INTERACTIVE SESSION 1: Clinical case with multidisciplinary team discussion Patient with liver metastases and… Moderators: Lluís Cirera and Esteban Cugat
15.45- 16.00 Intensive vs sequencial chemotherapy Fotios Loupakis
16.00- 16.15 R1 surgery Rene Adam
16.15- 16.30 Extreme surgery Joan Figueras
16.30- 16.45 ALPPS Julio Santoyo
16.45- 17.00 Molecular classification of CRC Miriam Cuatrecasas
17.00- 18.00 LECTURES Introduction: Esteban Cugat
17.00- 17.20 Liver transplantation in metastasic setting: an update Rene Adam
17.20- 17.30 Questions
17.30- 17.50 Functional assessment of rapidly growing liver Eric Schadde
17.50- 18.00 Questions
18.00- 18.30 Coffee Break
18.30- 19.40 LIVER METASTASES Moderators: Joan Figueras and Emilio Ramos
18.30- 18.45 Portal embolization Juan Carlos García-Valdecasas
18.45- 19.00 Laparoscopic surgery Ricardo Robles
19.00- 19.15 Robotic surgery Emilio de Vicente
19.15- 19.30 Surgical resection after second-line chemotherapy with aflibercept: Spanish experience Nuría Rodríguez
19.30- 19.40 Discussion
19.40- 20.20 LOCO-REGIONAL TREATMENTS Moderators: Esteban Cugat and Juan Carlos García-Valdecasas
19.40- 19.55 Radioembolization of liver metastases. A bridge to surgery Fernando Pardo
19.55- 20.10 Intraarterial treatments; an update Joan Falcó
20.10- 20.20 Questions
Programme Friday, november 13th, 201508.00- 09.25 INTERACTIVE SESSION 2: Clinical case with multidisciplinary team discussion Two patients with lung metastases, with complete response after oncologic treatment Moderators: Sergi Call and Esther Casado
08.00- 08.30 Clinical case presentation: Sergi Call and Esther Casado Expert opinión
08.30- 08.45 Surgical plan based on risk factors Raul Embún
08.45- 09.00 Role of targeted therapies Carles Pericay
09.00- 09.15 Lung metastasectomy after complete response? Paul Van Schil
09.15- 09.25 Discussion
09.25- 09.55 LECTURE Introduction: Lluís Cirera
09.25- 09.45 Liquid biopsy: present and future Jesús García-Foncillas
09.45- 09.55 Questions
09.55- 10.25 Coffee Break
10.25- 11.35 LUNG METASTASES Moderators: Laureano Molins and Ramón Rami-Porta
10.25- 10.40 What is the best approach in pulmonary metastasectomy? Paul Van Schil
10.40- 10.55 Pulmonary laser resections: Technical aspects and results in colorectal cancer Bernward Passlick
10.55- 11.10 Modeling survival data after lung metastasectomy. Results from the Spanish
Prospective Colorectal Metastasectomy Registry (GECMP-CCR) Raul Embún
11.10- 11.25 Nonexamination of lymph node and survival in lung metastasectomy. Results from
the Spanish Prospective Colorectal Metastasectomy Registry (GECMP-CCR) Sergi Call
11.25- 11.35 Discussion
11.35- 12.05 LECTURE Introduction: Ramón Rami-Porta
11.35-11.55 Accuracy of imaging techniques in the detection of pulmonary metastases Tomasz Grodzki
11.55 – 12.05 Questions
12.05- 13.00 EXTENT OF TUMOR RESPONSE: DOES IT MATTER? Moderators: Esther Casado and Marta Paraira
12.05- 12.20 What does depth response mean? Javier Gallego
12.20- 12.35 What does early tumor shrinkage (ETS) mean? Elena Elez
12.35- 12.50 Relation between radiological and surgical response Emilio Ramos
12.50- 13.00 Discussion
13.00- 13.30 LECTURE Introduction: Julen Fernández
13.00- 13.20 Resistance to anti-EGFR therapy Clara Montagut
13.20- 13.30 Questions
Programme Friday, november 13th, 2015
13.30- 14.00 POSTERS SESSION
Contributions of patient-, tumor-, and treatment-related factors to the patients outcome after curative liver resection among egyptian patients with metastatic colorectal tumorAmr Abdelaal1, khalid Elhusseiny2 , Mona Kamal21Ain Shams University. Faculty of Medicine-general Surgery Department. Egypt. Cairo; 2 Ain Shams University. Faculty of Medicine. Clinical Oncology Department. Egypt. Cairo
The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: focus on targeted agents. A review of randomized clinical trialsJacopo Giuliani, Andrea BonettiDepartment of Medical Oncology. Mater Salutis Hospital-AULSS 21 della Regione Veneto, Legnago (VR). Italy
Subcentimeter liver metastases diagnosed intraoperative on colorectal cancerLosada Villa B., De Torres Olombrada MV., Juez Martel I., Gutiérrez abad D., Guerra Martínez J.HU Fuenlabrada. Madrid. Spain
Differential diagnosis between cavernous hemangioma and liver metastases: Importance of Intraoperative ultrasound and biopsyDe Torres Olombrada MV., Losada Vila B., Gutierrez Abad D., Juez Martel I., Pereira Pérez F.H U Fuenlabrada, Madrid, Spain
Recent literature review and individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: a history of resected liver metastases worsens the prognosisJon Zabaleta, Tomohiko Iida, Samer Salah, José Ramon Jarabo, Pierre Falcoz, Shanda H Blackmon, Maria G. Zampino, Takashi Matsui, Sukki Cho (84 pac), Francesco Ardissone, Kazuhiro Watanabe, Michel Gonzalez, Pascal Gervaz, Jose I. EmparanzaThoracic Surgery Service, Donostia University Hospital
Oligometastatic colorectal carcinoma (CRC) patients treated with radical intention. Retrospective analysis of the experience in a single centreJulia Hidalgo-Coloma, Sara Marín, Javier Garde-Noguera, René Albino, Beatriz Honrubia, Enrique Cabrera, Juan Manuel CamposHospital Arnau de Vilanova. Valencia. Spain
1.
2.
3.
4.
5.
6.
14.00- 14.15 BEST POSTER AWARD
14.15 Adjournment Lluís Cirera
14.30 Lunch
Prognosis of lung metastases in colorectal cancerJaione Sáenz de Ugarte Sobrón, José Domingo Sardón Ramos, Baltasar Cermeño Toral, Alberto Gastón Moreno, Paula Siebel Hermida, Iñaki Martínez Rodríguez, Aintzane Maqueda Merino, María Cuadra Cestafe, Lorans Fernández Rico, Ane Etxart LopetegiDepartment of SurgeryAraba-Txagorritxu University Hospital. Basque Country. Spain
Liver only disease of Colorectal cancer: a different disease?Dr. Ana Fernandez Montes1, Dr. Mercedes Salgado1, Dr Manuel Trillo2, Dr. Jose Manuel Carrera2, Dr. Purification Froján3, Dr Alejo Muinello31 Department of Medical Oncology; 2 Department of Radiology; 3 Department of General Surgery. University Hospital Complex Ourense. Spain
Clinical implications of molecular and functional characterization in liver limited metastatic colorectal cancer. Vall d’hebrón university hospital programCarolina Ortiz1, Guillem Argilés1,2, Tamara Saurí1,2, Julieta Grasselli2, Cristina Dopazo1, Teresa Macarulla1,2, Jaume Capdevila1,2, Ignacio Matos1,2, María Alsina1,2, Cinta Hierro1,2, Helena Verdaguer1,2, Enrique Sanz-García1, Stefania Landolfi1, Paolo Nuciforo2, Rodrigo Dienstmann2, Ramón Charco1, Ana Vivancos2, Hector G. Palmer2, Elena Elez1,2 and Josep Tabernero1,21 Vall d’Hebron University Hospital. Barcelona. Spain; 2 Vall d’Hebron Institute of Oncology (VHIO). Barcelona. Spain
Agressive treatment for liver metastasis of squamous cell carcinomaGastón Moreno A, Saez de Ugarte Sobron J, Sardon Ramos J.D, Maqueda Merino A, Siebel Hermida P, Camuera Gonzalez M, Martinez Rodriguez I, Garcés Garmendia M.A, Rebollar Saenz J, Fernandez Rico L.H.U.A Txagorritxu. Vitoria. España
7.
8.
9.
10.
ParticipantsRenè Adam. Oncosurgical Unit. Hepatobiliary Center. University Paris Sud. Hôpital Paul-Brousse. Paris
Sergi Call. Thoracic Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Esther Casado. Oncology Service. Althaia. Xarxa Assistencial de Manresa. Manresa. Barcelona
Lluís Cirera. Oncology and Hematology Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Miriam Cuatrecasas. Pathology Service. Hospital Clínic. Barcelona
Esteban Cugat. Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Elena Elez. Medical Oncology Department. Hospital Vall d´Hebron. Barcelona
Raul Embún. Department of Thoracic Surger. Hospital Universitario Miguel Servet. Zaragoza
Joan Falcó. Vascular and interventional radiology Unit. Corporació Sanitària Parc Taulí. Sabadell. Barcelona
Jaime Feliu. Medical Oncology Service. Hospital Universitario La Paz. Madrid
Julen Fernández. Oncology and Hematology Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Joan Figueras. Hepatobiliary Surgery Unit. Hospital Universitari Doctor Josep Trueta. Girona
Javier Gallego. Medical Oncology Service. Hospital Universitario Elche. Elche. Alicante
Pilar García-Alfonso. Medical Oncology Service. Hospital Universitario Gregorio Marañón. Madrid
Jesús García-Foncillas. Oncology Department. Fundación Jiménez Díaz. Madrid
Juan Carlos García-Valdecasas. General and Digestive Surgery. Hospital Clínic. Barcelona
Tomasz Grodzki. Pomeranian Medical University. Poland
Fotios Loupakis. Medical Oncology Service Ospedale S. Chiara - Azienda Ospedaliero-Universitaria Pisana. Italy
Teresa Macarulla. Medical Oncology Service. Hospital Universitario Vall d’Hebron. Barcelona
Laureano Molins. Thoracic Surgery Service. Hospital Clínic. Barcelona
Clara Montagut. Oncology Department. Parc de Salut Mar. Hospital del Mar. Barcelona
Marta Paraira. Radiodiagnostic Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Fernando Pardo. Hepatobiliary Surgery Service. Clínica Universitaria de Navarra. Pamplona. Navarra
Benward Passlik. Department of Thoracic Surgery. Albert-Ludwigs-University Freiburg. Freiburg
Carles Pericay. Medical Oncology Service. Consorci Hospitalari Parc Taulí. Sabadell. Barcelona
Ramón Rami-Porta. Thoracic Surgery Service. Hospital Universitari MútuaTerrassa. Terrassa. Barcelona
Emilio Ramos. General and Digestive Surgery. Hospital Universitari de Bellvitge. L´Hospitalet de Llobregat. Barcelona
Ricardo Robles. Liver transplant Unit. Surgery Service. Hospital Universitario Virgen de la Arrixaca. Murcia
Nuría Rodríguez. Medical Oncology Department. Hospital Universitario La Paz. Madrid
Antonieta Salud. Medical Oncology Service. Hospital Universitario Arnau Villanova. Lleida
Julio Santoyo. General and Digestive Surgery. Hospital Carlos Haya. Málaga
Eric Schadde. Department of Surgery. Swiss HPB ans Transplant Center. University Hospital Zurich. Zurich
Paul Van Schil. Department of Thoracic and Vascular Surgery. University Hospital of Antwerp. Edegem
Ruth Vera. Medical Oncology Service. Complejo Hospitalario de Navarra. Navarra
Emilio de Vicente. Department of General and Digestive Surgery. Hospital Universitario Sanchinarro. Madrid
Sponsored symposiums 11.00- 12.00 Improving overall survival with panitumumab in metastatic colorectal cancer Sponsored by AMGEN
Introduction Jaime Feliu
What is the value of panitumumab in the treatment of metastatic colorectal cancer? Teresa Macarulla
What is the current evidence of panitumumab in the treatment of liver only metastatic colorectal cancer? Ruth Vera
12.00- 13.00 AVASTIN: 10 years provinding outcomes among mCRC patiens Sponsored by Roche
A different treatment approach for mCRC. Unresectable patients Fotios Loupakis
How can we treat unresectable liver metastases with AVASTIN in 2015? Pilar García-Alfonso
Discussion and conclusions Antonieta Salud
13.00- 14.00 Precision medicine, precision treatment Sponsored by Merck Serono
Cetuximab role within surgery of non-resectables metastases Joan Figueras
Standard chemotherapies – are they eligible for all anti-EGFR? Elena Élez
General Information
www.oncology-bcn.com
Dates: November 12th and 13th, 2015. Barcelona, (Spain)
Venue: Hotel NH Barcelona Constanza. St/ Deu i Mata, 69-99. 08029. Barcelona (Spain)
Language: The official languages of the Workshop will be English and Spanish. There will be simultaneous translation.
Technical Secretariat (registration and hotel reservation): ACTO SERVEISC/ Bonaire, 7. 08301 Mataró. Barcelona (Spain).Tel. +34 937 552 382 / Fax. +34 937 552 [email protected] | www.oncology-bcn.com
PostersThere will be a Euro 1,000.00 award to the best poster according to the evaluation of the Scientific Committee.
RegistrationRegistration Fees
Before September 15th After September 16th andon-site registration
Members of SEOM, GEMCAD, SEPAR, TTD, ESSO, AEC, ACROSS, ESMO, SECT
Others
Residents
650 €
750 €
450 €
690 €
790 €
490 €
*VAT (21% IVA) is included*
Registration documentation will be handed-out to the participants from the Meeting Secretariat.Registration forms will be only processed when received before November 2nd, 2015.After this date registration forms will be processed as on-site registrations.
RegistrationOn-line registration is possible through the web site www.oncology-bcn.comThis service will let you register and receive your confirmation letter on-line.The payment is possible by bank transfer and credit card.
Registration forms received without the complete contact address or without payment will not be accepted. Before November 2nd, 2015 registration will be possible on-site. The fees should be paid in Euros by bank transfer or credit card. Participants must bring the confirmation letter to the registration desk as proof of their registration.
Payment of Registration FeesEarly rates only apply when registration and payment are received before September 15th. When registrations and payments are received after September 16th 2015, then the corresponding late fees will automatically applyPayment in EURO (€) should be made in advance by bank transfer or credit card.
Bank to bank transfer to ACTO SERVEIS in Euro- BANK: BANKINTER- ACCOUNT NUMBER: 0128-0524-24-0100028872- IBAN: ES63 0128-0524-24-0100028872- SWIFT: BKBKESMMXXX- Reference: ACTOSERVEIS
Clearly mention name with the bank transfer.
Remittance should be free of charge to the recipient.
Registration cancellation policyAny cancellation must be notified in writing and will be subjected to the following conditions:Refund of fees: subject to a 25% administrative charge, will be applied to cancellations, made up to October 28th. No refund can be made after October 28th.
AcommodationHotel reservationThe Meeting Secretariat (ACTO SERVEIS) is in charge of hotel accommodation and will operate on a first-come first-served basis with the incoming requests.Due to heavy demand and to the fact that distribution of rooms is limited, accommodation cannot be guaranteed after September 15th, 2015.
Breakfast and VAT included. Prices are per room and nights. Deadline for guaranteed hotel reservations: September 15th, 2015.
The Technical Secretariat reserves the right to book another hotel/category if the desired one is fully booked. If this is necessary, participants will be notified as soon as possible.
Hotel requestOn-line hotel request is possible through the web site www.oncology-bcn.com.This service will let you register and receive your confirmation letter on-line.The payment is possible by bank transfer and credit card.
Hotel forms received without the complete contact address or without payment will not be accepted.
Participants must bring the hotel voucher to the hotel reception as proof of their reservation.
Payment details (Registration and Accommodation)Payment in EURO (€) should be made in advance by bank transfer or credit card.
Bank to bank transfer to ACTO SERVEIS in Euro- Bank: BANKINTER- ACCOUNT NUMBER: 0128-0524-24-0100028872- IBAN: ES63 0128-0524-24-0100028872- SWIFT: BKBKESMMXXX- Reference: ACTOSERVEIS
Single Room
Hotel NH Barcelona Constanza **** (St/ Deu i Mata, 69-99. Barcelona) 143,99€ 164,76€
Double Room
Clearly mention name with the bank transfer.Remittance should be free of charge to the recipient.- Reference: ACTOSERVEIS
Clearly mention name with the bank transfer.Remittance should be free of charge to the recipient.
Hotel Reservation Cancellation PolicyAny cancellation must be notified in writing and will be subjected to the following conditions:Accommodation Refunds: 50 % refund if cancelled before September 2nd, 2015; 25 % refund if cancelled from September 3rd to October 5th 2015; and no refund if cancelled after October 5th, 2015.
Lower Cost Accommodation
Younger visitors and those looking for alternative forms of accommodation will find youth hostels, halls of residence, some of them open all year round. In short, accommodation for all tastes and at prices to suit every pocket.
For more information about the city’s hotels please check the website www.barcelonaturisme.com (where to sleep).
Contact them directly to consult prices for short stays and make the reservation.
City informationBarcelona overlooks the Mediterranean and is located in a heavily populated area which is a hub of economic activity.
Barcelona enjoys a Mediterranean climate, with mild winters and warm summers.
It is a coastal city and has over four kilometres of urban beaches and large areas of nearby forest. Although it is a large city, it is easy to get around on public transport and on foot. You can reach any point in the city by metro, bus and taxi.
Barcelona is the capital of Catalonia. Its inhabitants are open and welcoming.
The people of Barcelona speak Catalan, their own language, and Spanish. Many of them also understand a little English and French
VisaSpain is part of the Schengen zone. This means that nationals from EU countries do not need a visa.
LenguageMost of Barcelona’s inhabitants are bilingual and speak Catalan, their own language, and Spanish.
ElectricityThe voltage in Spain is 220 volts, 50 Hz. The plug types are C and F.
ClimateThe city has a typically Mediterranean climate and enjoys pleasant temperatures all the year round.
CurrencyThe euro (€) is the official currency of the European Union and can be exchanged at savings banks and banks.
BanksBusiness hours differ between banks. Most banks are open from Monday to Friday from 08:15 to 14:15.
CustomsIn Barcelona mealtimes are usually a little later than the rest of Europe. The city’s shops have long opening hours.
Shopping in BarcelonaMonday to Saturday, from 09:30 to 13:30 and from 16:30 to 20:00. Most of the department stores do not close at mid-day.
Notes
www.oncology-bcn.com
Academic support:
This Workshop has been accrediteed with 9 ESMO-MORA points
This Workshop was granted 6 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).
Supported by:
Technical SecretariatACTO SERVEISC/ Bonaire, 7. 08301 Mataró. Barcelona (Spain).Tel. +34 937 552 382 / Fax. +34 937 552 [email protected]
www.oncology-bcn.com